Life-threatening toxic epidermal necrolysis during voriconazole therapy for invasive aspergillosis after chemotherapy

被引：14

作者：

Curigliano, G. ^{[1
]}

Formica, V.

De Pas, T.

Spitaleri, G.

Pietri, E.

Fazio, N.

de Braud, F.

Goldhirsch, A.

机构：

[1] European Inst Oncol, Dept Med, Milan, Italy

[2] European Inst Oncol, Clin Pharmacol Unit, Milan, Italy

来源：

ANNALS OF ONCOLOGY | 2006年 / 17卷 / 07期

关键词：

D O I：

10.1093/annonc/mdj126

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

引用

页码：1174 / 1175

页数：2

共 2 条

[1]

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis [J].

Herbrecht, R ;

Denning, DW ;

Patterson, TF ;

Bennett, JE ;

Greene, RE ;

Oestmann, JW ;

Kern, WV ;

Marr, KA ;

Ribaud, P ;

Lortholary, O ;

Sylvester, R ;

Rubin, RH ;

Wingard, JR ;

Stark, P ;

Durand, C ;

Caillot, D ;

Thiel, E ;

Chandrasekar, PH ;

Hodges, MR ;

Schlamm, HT ;

Troke, PF ;

de Pauw, B .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (06) :408-415

[2]

Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin [J].

Viard, I ;

Wehrli, P ;

Bullani, R ;

Schneider, P ;

Holler, N ;

Salomon, D ;

Hunziker, T ;

Saurat, JH ;

Tschopp, J ;

French, LE .

SCIENCE, 1998, 282 (5388) :490-493

← 1 →